KRYSTAL BIOTECH INC (KRYS) Stock Income Statement
NASDAQ:KRYS - Nasdaq - US5011471027 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 333.45M | 290.51M | 50.70M | 0.00 | 0.00 | |||
| Cost Of Goods | 22.67M | 20.06M | 3.09M | N/A | N/A | |||
| Gross Profit | 310.78M | 270.45M | 47.60M | N/A | N/A | |||
| Operating Expenses | 177.22M | 167.26M | 144.83M | 120.20M | 68.28M | |||
| Research and Development | 56.87M | 53.57M | 46.43M | 42.46M | 27.88M | |||
| Selling, General, and Administrative Expenses | 120.35M | 113.69M | 98.40M | 77.74M | 40.39M | |||
| Operating Income | 133.56M | 103.19M | -97.23M | -120.20M | -68.28M | |||
| Interest Income/Expense | 29.47M | 29.66M | 22.62M | 5.22M | -1.30M | |||
| Non Recurring Items | -25.00M | -37.50M | 87.50M | -25.00M | N/A | |||
| Income Before Taxes | 138.02M | 95.36M | 12.90M | -139.98M | -69.57M | |||
| Income Tax | 14.06M | 6.20M | 1.97M | N/A | N/A | |||
| Net Income | 123.96M | 89.16M | 10.93M | -139.98M | -69.57M | |||
| EBITDA | 140.48M | 109.91M | -92.22M | -116.14M | -65.51M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 4.15 | 3.00 | 0.39 | -5.49 | -3.13 | |||
| Non GAAP EPS | 4.16 | 2.99 | -3.40 | -4.51 | -3.06 | |||
| Statistics | ||||||||
| Gross Profit Margin | 93.20% | 93.09% | 93.90% | N/A | N/A | |||
| Profit Margin | 37.18% | 30.69% | 21.56% | N/A | N/A | |||
| Operating Profit Margin | 40.05% | 35.52% | -191.77% | N/A | N/A | |||
All data in USD